News | Page 15 | Graduate School of Medical Sciences

cyan strands of DNA wrapped around green histone proteins

Discovery Suggests New Strategy Against Follicular Lymphoma

A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of a type of blood cancer called follicular lymphoma from a slow-growing form to the aggressive form it takes in some patients.

The study, published March 7 in Cancer Cell, showed that while mutations affecting a gene-regulating complex called BAF can put the cancer on a dangerous trajectory, they also make follicular lymphoma highly susceptible to experimental BAF-inhibitor drugs...

Stand Up To Cancer Dream Team Collective Seeks to Transform Care of Gastroesophageal Cancer

A collaboration between Dr. Jedd Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, and Dr. Yelena Janjigian, chief of the gastrointestinal oncology service at Memorial Sloan Kettering Cancer Center, is looking to transform the care of gastroesophageal cancer (GEC) patients with untreatable disease – earning the pair a grant from Stand Up To Cancer® (SU2C) as a part of the SU2C-Torrey Coast Foundation Gastroesophageal Cancer Dream Team...

2024 Health Hackathon Yields Innovative Solutions for Enhancing Patient Safety

The 2024 Health Hackathon brought together 185 students with diverse backgrounds from Cornell and 26 other universities—in just 36 hours, they addressed critical safety challenges facing patients today.

The competition, held in person from March 8-10 and organized by Weill Cornell Medicine’s Clinical & Translational Science Center (CTSC) and Entrepreneurship at Cornell, had multidisciplinary teams of future researchers, engineers, physicians, computer scientists and businessmen...

NSF Awards Grant for Evolution-inspired Design of Therapeutic RNAs

A team led by Dr. Samie Jaffrey, the Greenberg-Starr Professor of Pharmacology at Weill Cornell Medicine, has been awarded a three-year, $1.65 million grant for RNA research under a biotechnology-development program run by the U.S. National Science Foundation.

The competitive Molecular Foundations for Biotechnology program funds cutting-edge research that lays the groundwork for future clinical and industrial biotechnologies. The new award is one of nine that have been given to...

Photo of a hand holding a stethoscope on a man's arm with a blood pressure cuff

Peer Coaching Helps Marginalized Individuals Lower Blood Pressure

For younger Black patients living in rural parts of the Southeastern United States, peer coaching is more effective than traditional clinical care in controlling high blood pressure, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian. The investigators learned that for people under age 60 who have persistently uncontrolled hypertension, the benefits of working with a peer health coach were equivalent to what would be expected from taking a low...

green and red labeled cells generated by imaging mass cytometry

Mapping the Evolution of Urinary Tract Cancer Cells

Researchers at Weill Cornell Medicine have performed the most comprehensive analysis to date of cancer of the ureters or the urine-collection cavities in the kidney, known as upper tract urothelial carcinoma (UTUC). The study, which compared the characteristics of primary and metastatic tumors, provides new insights into the biology of these aggressive cancers and potential ways to treat them.

In the study, which appeared March 18 in Nature Communications, the researchers examined...

immunofluorescence image showing phospholipids in condensates

Discovery Reveals Lipid-Signaling Microdomains in Cells

Important signaling molecules called phospholipids are active throughout cells in small compartments called condensates, rather than functioning primarily in cell membranes as previously thought, according to a study from researchers at Weill Cornell Medicine. The finding helps open a new avenue of investigation in cell biology and may also be relevant to the study of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Alzheimer’s disease.

Condensates in cells,...

Drs. Jedd Wolchok and Taha Merghoub in a lab

Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium

San Francisco and New York — Dec. 13, 2023 — The Parker Institute for Cancer Immunotherapy (PICI), the largest concentration of immuno-oncology (IO) expertise in the world, announced it has added Weill Cornell Medicine to its network of preeminent academic and medical research institutions at the forefront of the fight against cancer. Under the agreement, Weill Cornell Medicine, with new PICI Network researchers, will establish a PICI immuno-oncology research center in New York City.

...

Graduate Students Share Cutting-Edge Research in Three-Minute Talks

Three minutes and one projected slide–that’s all each graduate student had to present a big-picture research goal to a non-specialist audience in a way they could understand and appreciate.

The eleven students from the Weill Cornell Graduate School of Medical Sciences and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences participated in the eighth annual Three-Minute Thesis (3MT®) competition, which challenged the young scientists to trim the scientific jargon and...

external rendering of a building during daylight.

Weill Cornell Medicine Announces New Residence for Graduate and Medical Students, Expanding Scope of Upper East Side Campus

Video of New Student Residence at Weill Cornell Medicine

NEW YORK (Oct. 17, 2023)—Weill Cornell Medicine is constructing a modern new student residence that, when it opens in 2025, will expand the scope of the institution’s Upper East Side campus and nearly double the existing student residential living space.

The new $260 million, 16-story, 173,000-square-foot residence is located on the northwest corner of East 74th Street and York Avenue, four blocks from Weill Cornell...